|
US601101A
(en)
|
|
1898-03-22 |
|
Cross-tie |
|
DE1116676B
(de)
|
1955-03-14 |
1961-11-09 |
Thomae Gmbh Dr K |
Verfahren zur Herstellung von Pyrimido [5, 4-d] pyrimidinen
|
|
GB1051218A
(enExample)
|
1963-03-09 |
|
|
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3636039A
(en)
|
1970-02-24 |
1972-01-18 |
Hoffmann La Roche |
Substituted benzylimidazolidinones
|
|
GB1361441A
(en)
|
1970-05-13 |
1974-07-24 |
Sandoz Ltd |
Benzonaphthyridine derivatives
|
|
GB1338235A
(en)
|
1970-12-15 |
1973-11-21 |
May & Baker Ltd |
Azapurinones
|
|
BE794964A
(fr)
|
1972-02-04 |
1973-08-02 |
Bristol Myers Co |
Nouveaux agents hypotenseurs et procede pour les preparer
|
|
JPS5229318B2
(enExample)
|
1972-03-30 |
1977-08-01 |
|
|
|
DE2305339C3
(de)
|
1973-02-03 |
1980-05-08 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
|
|
AR205004A1
(es)
|
1973-10-30 |
1976-03-31 |
Ishikawa M |
Procedimiento para preparar derivados de 6,8-dialquil-7-alcoxi-carbonil-4-hidroximetil-1-ftalazona y la 7,8-lactona
|
|
US4016166A
(en)
|
1973-12-14 |
1977-04-05 |
Hisamitsu Pharmaceutical Co., Inc. |
1-Nitrophenylquinazoline-2,4(1H,3H)-diones
|
|
DE2402908C2
(de)
|
1974-01-22 |
1982-12-02 |
Fa. Johann A. Wülfing, 4040 Neuss |
7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung
|
|
DE2413935A1
(de)
|
1974-03-20 |
1975-10-16 |
Schering Ag |
4-(polyalkoxy-phenyl)-2-pyrrolidone
|
|
US4072746A
(en)
|
1975-10-14 |
1978-02-07 |
Sterling Drug Inc. |
3-Amino-5-(pyridinyl)-2(1H)-pyridinones
|
|
NZ187452A
(en)
|
1977-06-10 |
1980-05-27 |
Otsuka Pharma Co Ltd |
N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
|
|
DE2727481A1
(de)
|
1977-06-18 |
1979-01-11 |
Basf Ag |
Dihydropyridazone und dihydropyridazone enthaltende therapeutische mittel
|
|
NL7807507A
(nl)
|
1977-07-25 |
1979-01-29 |
Hoffmann La Roche |
Tricyclische verbindingen.
|
|
CA1114379A
(en)
|
1977-11-03 |
1981-12-15 |
Pfizer Corporation |
Piperidino-phthalazines
|
|
JPS5527105A
(en)
|
1978-08-11 |
1980-02-27 |
Dai Ichi Seiyaku Co Ltd |
Imidazothienopyrimidinones compound
|
|
DE2837161A1
(de)
|
1978-08-25 |
1980-03-06 |
Thomae Gmbh Dr K |
Neue benzimidazole und deren verwendung
|
|
JPS5535019A
(en)
|
1978-09-01 |
1980-03-11 |
Otsuka Pharmaceut Co Ltd |
Carbostyryl derivative
|
|
DE2845220A1
(de)
|
1978-10-17 |
1980-04-30 |
Yoshitomi Pharmaceutical |
Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
|
|
DE2847693A1
(de)
|
1978-11-03 |
1980-05-22 |
Hoechst Ag |
Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
|
|
NZ193935A
(en)
|
1979-06-18 |
1985-05-31 |
Richardson Merrell Inc |
4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
|
|
GB2063249A
(en)
|
1979-10-09 |
1981-06-03 |
Mitsubishi Yuka Pharma |
4-Phenylphthalazine derivatives
|
|
NZ195564A
(en)
|
1979-11-26 |
1983-09-30 |
Sterling Drug Inc |
5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds
|
|
JPS5777676A
(en)
|
1980-10-31 |
1982-05-15 |
Otsuka Pharmaceut Co Ltd |
Carbostyril derivative
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4405628A
(en)
|
1981-03-05 |
1983-09-20 |
Merrell Dow Pharmaceuticals Inc. |
4-Pyridylimidazolones and method of use
|
|
HU190412B
(en)
|
1981-09-17 |
1986-09-29 |
Warner-Lambert Co,Us |
Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
|
|
EP0096517A3
(en)
|
1982-06-05 |
1985-04-03 |
Smith Kline & French Laboratories Limited |
Aryl pyrazinones
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
|
US4490371A
(en)
|
1983-02-16 |
1984-12-25 |
Syntex (U.S.A.) Inc. |
N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
|
|
US4503030A
(en)
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
|
GB8400863D0
(en)
|
1984-01-13 |
1984-02-15 |
Smith Kline French Lab |
Chemical compounds
|
|
GB8406906D0
(en)
|
1984-03-16 |
1984-04-18 |
Akzo Nv |
Benzo-thiazole and benzothiophene derivatives
|
|
DK159431C
(da)
|
1984-05-10 |
1991-03-18 |
Byk Gulden Lomberg Chem Fab |
6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
|
|
GR851085B
(enExample)
|
1984-05-12 |
1985-11-25 |
Boehringer Mannheim Gmbh |
|
|
ZA853440B
(en)
|
1984-05-14 |
1986-12-30 |
Lilly Co Eli |
Indoline and 2-indolinone derivatives
|
|
DE3424685A1
(de)
|
1984-07-05 |
1986-02-06 |
Beiersdorf Ag, 2000 Hamburg |
Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
|
|
JPS61218589A
(ja)
|
1985-03-26 |
1986-09-29 |
Eisai Co Ltd |
５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
|
|
US4931279A
(en)
|
1985-08-16 |
1990-06-05 |
Bausch & Lomb Incorporated |
Sustained release formulation containing an ion-exchange resin
|
|
US4713244A
(en)
|
1985-08-16 |
1987-12-15 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
|
|
US4668506A
(en)
|
1985-08-16 |
1987-05-26 |
Bausch & Lomb Incorporated |
Sustained-release formulation containing and amino acid polymer
|
|
DE3677316D1
(de)
|
1985-10-17 |
1991-03-07 |
Smith Kline French Lab |
4(4-oxo-1,4-dihydropyridin-1-yl)phenyl-derivate.
|
|
IL77186A0
(en)
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
|
HU215433B
(hu)
|
1986-04-29 |
2000-05-28 |
Pfizer Inc. |
Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
|
|
ES2033922T3
(es)
|
1986-08-28 |
1993-04-01 |
Sandoz Ag |
Procedimiento para preparar nuevos derivados de xantina.
|
|
NZ222843A
(en)
|
1986-12-22 |
1989-10-27 |
Ortho Pharma Corp |
Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
|
|
GB8630702D0
(en)
|
1986-12-23 |
1987-02-04 |
Wellcome Found |
Quinoline compound
|
|
CA1303037C
(en)
|
1987-02-02 |
1992-06-09 |
Smith Kline & French Laboratories Limited |
Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
|
|
AU614965B2
(en)
|
1987-06-06 |
1991-09-19 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Thiadiazinones
|
|
NZ225447A
(en)
|
1987-07-20 |
1991-12-23 |
Merck & Co Inc |
Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
|
|
GB2209937B
(en)
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
|
DE68907066T2
(de)
|
1988-01-29 |
1993-12-16 |
Koken Kk |
Verbesserte Formulierungen mit kontrollierter Abgabe.
|
|
JP2717687B2
(ja)
|
1988-02-13 |
1998-02-18 |
日本曹達株式会社 |
ピリダジノン誘導体及びその製造方法
|
|
US5142096A
(en)
|
1988-03-31 |
1992-08-25 |
Kyowa Hakko Kogyo Co., Ltd. |
2,4-dihydroxy-3,5,6-trimethylbenzoic acid compounds
|
|
GB8812490D0
(en)
|
1988-05-26 |
1988-06-29 |
Agricultural & Food Res |
Delayed release formulations
|
|
JP2792862B2
(ja)
|
1988-07-30 |
1998-09-03 |
寛治 高田 |
経口腸溶製剤
|
|
JPH0710875B2
(ja)
|
1989-03-10 |
1995-02-08 |
雪印乳業株式会社 |
シアル酸類含有脱塩乳糖の製造方法
|
|
GB8906792D0
(en)
|
1989-03-23 |
1989-05-10 |
Beecham Wuelfing Gmbh & Co Kg |
Treatment and compounds
|
|
US5007790A
(en)
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
|
AU640137B2
(en)
|
1989-04-17 |
1993-08-19 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Novel arylpyridazines, their manufacture, use and medicaments containing them
|
|
NZ234186A
(en)
|
1989-07-07 |
1991-10-25 |
Janssen Pharmaceutica Nv |
Imidazo quinazolin-one derivatives and pharmaceutical compositions
|
|
GB9413975D0
(en)
|
1994-07-11 |
1994-08-31 |
Fujisawa Pharmaceutical Co |
New heterobicyclic derivatives
|
|
CH679207A5
(enExample)
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
|
US5219573A
(en)
*
|
1989-10-17 |
1993-06-15 |
Hershey Foods Corporation |
L-sugar laxatives
|
|
US4943573A
(en)
|
1989-11-01 |
1990-07-24 |
Bristol-Myers Squibb Company |
Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
|
|
CZ280006B6
(cs)
|
1989-11-13 |
1995-09-13 |
Pfizer Inc. |
Způsob přípravy opticky aktivního (2S) nebo (2R)-endobicyklo-2.2.1heptan-2-olu
|
|
GB8929208D0
(en)
|
1989-12-27 |
1990-02-28 |
Almirall Lab |
New xanthine derivatives
|
|
US4963561A
(en)
|
1990-02-28 |
1990-10-16 |
Sterling Drug Inc. |
Imidazopyridines, their preparation and use
|
|
US5175003A
(en)
|
1990-04-06 |
1992-12-29 |
Biosytes Usa, Inc. |
Dual mechanism controlled release system for drug dosage forms
|
|
ES2149761T3
(es)
|
1990-04-25 |
2000-11-16 |
Nissan Chemical Ind Ltd |
Derivado de piridazinona.
|
|
IL98087A
(en)
|
1990-05-04 |
1996-11-14 |
Perio Prod Ltd |
Preparation for dispensing drugs in the colon
|
|
MY105344A
(en)
|
1990-05-16 |
1994-09-30 |
Byk Gulden Lomberg Chemische Fabrik |
New sulphonyl compounds
|
|
GB9013750D0
(en)
|
1990-06-20 |
1990-08-08 |
Pfizer Ltd |
Therapeutic agents
|
|
WO1992000968A1
(en)
|
1990-07-10 |
1992-01-23 |
Smithkline Beecham Corporation |
Oxamides
|
|
CA2046830C
(en)
|
1990-07-19 |
1999-12-14 |
Patrick P. Deluca |
Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
|
|
US5124455A
(en)
|
1990-08-08 |
1992-06-23 |
American Home Products Corporation |
Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
|
|
WO1992006963A1
(de)
|
1990-10-16 |
1992-04-30 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Arylpyridazinone
|
|
GB9027055D0
(en)
|
1990-12-13 |
1991-02-06 |
Sandoz Ltd |
Organic compounds
|
|
JPH04234389A
(ja)
|
1990-12-28 |
1992-08-24 |
Sapporo Breweries Ltd |
ナフチリジン誘導体及びそれを有効成分とする抗潰瘍剤
|
|
US5141931A
(en)
|
1991-01-03 |
1992-08-25 |
Sterling Winthrop Inc. |
5-Quinolinylpyridinones, cardiotonic compositions and methods
|
|
IE71647B1
(en)
|
1991-01-28 |
1997-02-26 |
Rhone Poulenc Rorer Ltd |
Benzamide derivatives
|
|
IE73235B1
(en)
|
1991-03-25 |
1997-05-21 |
Akzo Nv |
4-aryl-thiazole or imidazole derivatives
|
|
US5449676A
(en)
|
1991-04-26 |
1995-09-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Pyridazines
|
|
US5191084A
(en)
|
1991-05-01 |
1993-03-02 |
American Home Products Corporation |
Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
|
|
CH683149A5
(fr)
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
|
GB9116039D0
(en)
|
1991-07-25 |
1991-09-11 |
Ucb Sa |
Substituted cyclopropylamino-1,3,5-triazines
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
JP3245165B2
(ja)
|
1991-10-09 |
2002-01-07 |
シンテックス（ユー・エス・エイ）・インコーポレイテッド |
ピリドピリダジノンおよびピリダジンチオン化合物
|
|
AU3588693A
(en)
|
1992-01-29 |
1993-09-01 |
Smithkline Beecham Corporation |
N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as TNF and PDE IV inhibitors
|
|
WO1993015045A1
(en)
|
1992-01-29 |
1993-08-05 |
Smithkline Beecham Corporation |
N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives
|
|
GB9204808D0
(en)
|
1992-03-04 |
1992-04-15 |
Rhone Poulenc Rorer Ltd |
Novel compositions of matter
|
|
US5264437A
(en)
|
1992-03-20 |
1993-11-23 |
Syntex (U.S.A.) Inc. |
Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
|
|
WO1993019747A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
|
EP0633771A4
(en)
|
1992-04-02 |
1995-02-22 |
Smithkline Beecham Corporation |
Compounds.
|
|
FI944549L
(fi)
|
1992-04-02 |
1994-11-30 |
Smithkline Beecham Corp |
Allergisten ja tulehdussairauksien hoidossa käyttökelpoiset yhdisteet
|
|
WO1993019751A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
|
|
GB9211268D0
(en)
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
|
CA2114114C
(en)
|
1992-06-15 |
2005-05-03 |
Nigel Robert Arnold Beeley |
Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors
|
|
JP2657760B2
(ja)
|
1992-07-15 |
1997-09-24 |
小野薬品工業株式会社 |
４−アミノキナゾリン誘導体およびそれを含有する医薬品
|
|
IL106517A0
(en)
|
1992-07-28 |
1994-08-26 |
Rhone Poulenc Rorer Ltd |
Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic or heteroatom containing linking group
|
|
ES2132254T3
(es)
|
1992-09-14 |
1999-08-16 |
Forssmann Wolf Georg Prof Dr |
Nueva utilizacion de inhibidores de la fosfodiesterasa iv.
|
|
DK0661989T3
(da)
|
1992-09-21 |
1998-03-02 |
Upjohn Co |
Proteinsammensætninger med vedvarende frigivelse
|
|
DK0672031T3
(da)
|
1992-12-02 |
2003-06-10 |
Pfizer |
Catecholdiethere som selektive PDE IV-inhibitorer
|
|
TW263495B
(enExample)
|
1992-12-23 |
1995-11-21 |
Celltech Ltd |
|
|
US5672659A
(en)
|
1993-01-06 |
1997-09-30 |
Kinerton Limited |
Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
|
|
PL174772B1
(pl)
|
1993-01-06 |
1998-09-30 |
Kinerton Ltd |
Kompozycja farmaceutyczna zawierająca jonowy konjugat cząsteczkowy
|
|
US5358502A
(en)
|
1993-02-25 |
1994-10-25 |
Pfizer Inc |
PH-triggered osmotic bursting delivery devices
|
|
GB9304919D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
|
US5455252A
(en)
|
1993-03-31 |
1995-10-03 |
Syntex (U.S.A.) Inc. |
Optionally substituted 6,8-quinolines
|
|
US5459151A
(en)
|
1993-04-30 |
1995-10-17 |
American Home Products Corporation |
N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
|
|
GB9309324D0
(en)
|
1993-05-06 |
1993-06-16 |
Bayer Ag |
Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
|
|
GB9311282D0
(en)
|
1993-06-01 |
1993-07-21 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
|
JPH0710875A
(ja)
|
1993-06-21 |
1995-01-13 |
Green Cross Corp:The |
選択的ホスホジエステラーゼｉｖ阻害剤
|
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
|
CZ290266B6
(cs)
|
1993-07-02 |
2002-06-12 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Substituované benzamidy, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
|
|
CN1048015C
(zh)
|
1993-07-06 |
2000-01-05 |
美国辉瑞有限公司 |
双环四氢吡唑并吡啶类化合物
|
|
GB9315595D0
(en)
|
1993-07-28 |
1993-09-08 |
Res Inst Medicine Chem |
New compounds
|
|
ZA945609B
(en)
|
1993-07-28 |
1995-05-12 |
Rhone Poulenc Rorer Ltd |
[Di(ether or thioether)heteroaryl or fluoro substituted aryl] compounds
|
|
JPH09501420A
(ja)
|
1993-07-30 |
1997-02-10 |
スミスクライン・ビーチャム・コーポレイション |
３−シアノ−３−（３，４−二置換）フェニルシクロヘキシル−１−カルボキシレート類
|
|
WO1995005386A1
(en)
|
1993-08-19 |
1995-02-23 |
Smithkline Beecham Corporation |
Phenethylamine compounds
|
|
US5665754A
(en)
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
|
WO1995009836A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Cyanocyclohexane compounds, compositions, and uses thereof
|
|
JPH09503503A
(ja)
|
1993-10-01 |
1997-04-08 |
スミスクライン・ビーチャム・コーポレイション |
化合物、組成物ならびにアレルギーおよび炎症の治療
|
|
EP0727990B1
(en)
|
1993-10-01 |
2001-06-13 |
Smithkline Beecham Corporation |
Compounds, compositions and treatment of allergies and inflammation
|
|
WO1995009623A1
(en)
|
1993-10-01 |
1995-04-13 |
Smithkline Beecham Corporation |
Anti-allergic, anti-inflammatory compounds, compositions and uses
|
|
GB9322828D0
(en)
|
1993-11-05 |
1993-12-22 |
Sandoz Ltd |
Organic compounds
|
|
CA2176719C
(en)
|
1993-11-17 |
2007-09-18 |
Geoffrey Anisson |
Fatty acid delivery system
|
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
|
CZ283564B6
(cs)
|
1993-11-26 |
1998-05-13 |
Pfizer Inc. |
3-Aryl-2-isoxazolin-5-hydroxamové kyseliny a farmaceutické prostředky na jejich bázi
|
|
JP2818820B2
(ja)
|
1993-11-26 |
1998-10-30 |
ファイザー・インク． |
抗炎症剤としての３−アリール−２−イソオキサゾリン類
|
|
EP0738268B1
(en)
|
1993-12-22 |
2004-03-03 |
Celltech R&D Limited |
Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
|
|
GB9326699D0
(en)
|
1993-12-22 |
1994-03-02 |
Celltech Ltd |
Chemical compounds
|
|
US5508300A
(en)
|
1994-01-14 |
1996-04-16 |
Pfizer Inc. |
Dihydro pyrazolopyrroles, compositions and use
|
|
JP2928079B2
(ja)
|
1994-02-14 |
1999-07-28 |
永信薬品工業股▲ふん▼有限公司 |
１−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途
|
|
ES2130597T3
(es)
|
1994-02-17 |
1999-07-01 |
American Home Prod |
Derivados de bifenilo sustituido como inhibidores de la fosfodiesterasa.
|
|
CA2143143A1
(en)
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
|
GB9404706D0
(en)
|
1994-03-11 |
1994-04-27 |
Smithkline Beecham Corp |
Compounds
|
|
US5952314A
(en)
|
1994-04-01 |
1999-09-14 |
Demichele; Stephen Joseph |
Nutritional product for a person having ulcerative colitis
|
|
WO1995027692A1
(en)
|
1994-04-08 |
1995-10-19 |
Smithkline Beecham Corporation |
Subtituted biphenyl tnf inhibitors
|
|
DE69532238T2
(de)
|
1994-04-21 |
2004-10-21 |
Schering Ag |
Pde iv-inhibitoren zur behandlung der multiplen sklerose
|
|
ATE226090T1
(de)
|
1994-04-22 |
2002-11-15 |
Yamanouchi Pharma Co Ltd |
Kolon-spezifisches arzneistofffreisetzungssystem
|
|
GB9410877D0
(en)
|
1994-05-31 |
1994-07-20 |
Bayer Ag |
Heterocyclycarbonyl substituted benzoduranyl-and-thiophenyl-alkanecarboxyclic acid derivatives
|
|
ES2127966T3
(es)
|
1994-05-31 |
1999-05-01 |
Bayer Ag |
Derivados de amino-benzofurilo y -benzotienilo.
|
|
HRP950288A2
(en)
|
1994-05-31 |
1997-08-31 |
Bayer Ag |
Oxalylamino-benzofuran- and benzothienyl-derivatives
|
|
US5786354A
(en)
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
|
GB9412383D0
(en)
|
1994-06-21 |
1994-08-10 |
Celltech Ltd |
Chemical compound
|
|
JP3056788B2
(ja)
|
1994-06-24 |
2000-06-26 |
ユーロ−セルティーク，エス．エイ． |
ホスホジエステラーゼｉｖの阻害化合物および阻害方法
|
|
US5466697A
(en)
|
1994-07-13 |
1995-11-14 |
Syntex (U.S.A.) Inc. |
8-phenyl-1,6-naphthyridin-5-ones
|
|
ES2152414T3
(es)
|
1994-07-22 |
2001-02-01 |
Byk Gulden Lomberg Chem Fab |
Dihidrobenzofuranos.
|
|
AU699489B2
(en)
|
1994-10-12 |
1998-12-03 |
Euro-Celtique S.A. |
Novel benzoxazoles
|
|
US5612052A
(en)
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US5877224A
(en)
|
1995-07-28 |
1999-03-02 |
Rutgers, The State University Of New Jersey |
Polymeric drug formulations
|
|
AUPN634595A0
(en)
*
|
1995-11-03 |
1995-11-30 |
Borody, Thomas Julius |
Improved method for colonic evacuation
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
IL126422A
(en)
|
1996-04-23 |
2004-02-19 |
Kinerton Ltd |
Biodegradable acidic polylactic polymers and methods for their preparation
|
|
WO1998009537A1
(en)
|
1996-09-09 |
1998-03-12 |
Kiwitech Limited |
Acid casein or a non-toxic soluble salt thereof and high-methoxyl pectin polymer
|
|
US5972389A
(en)
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
HRP970493A2
(en)
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
|
CA2217134A1
(en)
|
1996-10-09 |
1998-04-09 |
Sumitomo Pharmaceuticals Co., Ltd. |
Sustained release formulation
|
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
|
US5893985A
(en)
|
1997-03-14 |
1999-04-13 |
The Lincoln Electric Company |
Plasma arc torch
|
|
JPH10324642A
(ja)
|
1997-03-26 |
1998-12-08 |
Meiji Seika Kaisha Ltd |
大腸送達性構造体
|
|
AU745361B2
(en)
*
|
1997-04-18 |
2002-03-21 |
Janssen Pharmaceutica N.V. |
Use of 5HT3 antagonists for promoting intestinal lavage
|
|
DE19830375A1
(de)
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
|
MX339071B
(es)
|
1999-03-31 |
2016-05-09 |
Janssen Pharmaceutica Nv |
Almidon pregelatinizado en una formulacion de liberacion controlada.
|
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
|
WO2001001964A2
(en)
|
1999-06-23 |
2001-01-11 |
Sedum Laboratories, Inc. |
Ionically formulated biomolecule microcarriers
|
|
JP4303438B2
(ja)
|
1999-08-18 |
2009-07-29 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
ペプチドの持続放出製剤
|
|
JP4917726B2
(ja)
|
1999-12-31 |
2012-04-18 |
ルトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー |
ポリマー混合物および活性化合物からなる徐放用医薬製剤
|
|
WO2001049249A2
(en)
|
1999-12-31 |
2001-07-12 |
Rutgers, The State University |
Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
|
|
US7521061B2
(en)
|
1999-12-31 |
2009-04-21 |
Rutgers, The State University Of New Jersey |
Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
|
|
US20030064105A1
(en)
|
2000-08-25 |
2003-04-03 |
Myung-Jin Kim |
Lipophilic-coated microparticle containing a protein drug and formulation comprising same
|
|
PH12001000675B1
(en)
|
2000-04-04 |
2009-09-22 |
Australian Food Ind Sci Ct |
Encapsulation of food ingredients
|
|
CA2406077C
(en)
|
2000-04-10 |
2010-07-20 |
Nicholas J. Wald |
Formulation for the prevention of cardiovascular disease
|
|
CN1630532A
(zh)
|
2000-04-19 |
2005-06-22 |
约翰斯霍普金斯大学 |
预防和治疗胃肠疾病的方法
|
|
GB0025208D0
(en)
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
|
DE10055857A1
(de)
|
2000-11-10 |
2002-08-22 |
Creative Peptides Sweden Ab Dj |
Neue pharmazeutische Depotformulierung
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
WO2002058672A2
(en)
|
2001-01-26 |
2002-08-01 |
Debio Recherche Pharmaceutique S.A. |
Microparticles of biodegradable polymer encapsulating a biologically active substance
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
KR20040047747A
(ko)
|
2001-03-13 |
2004-06-05 |
펜웨스트 파머슈티칼즈 컴파니 |
변시치료 제형
|
|
JP2005511477A
(ja)
|
2001-03-19 |
2005-04-28 |
プラエシス ファーマシューティカルズ インコーポレーテッド |
持続放出のための医薬調合物
|
|
WO2002078683A1
(en)
|
2001-03-29 |
2002-10-10 |
Synergy Pharmaceuticals, Inc. |
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
|
|
ES2464532T3
(es)
|
2001-04-19 |
2014-06-03 |
The Scripps Research Institute |
Métodos y composiciones para la producción de pares ortogonales de ARNt-aminoacil-ARNt sintetasa
|
|
BR0209863A
(pt)
|
2001-05-18 |
2004-06-08 |
Sucampo Ag |
Composição catártica
|
|
WO2003007913A2
(en)
|
2001-07-20 |
2003-01-30 |
Samir Mitragotri |
Method for oral drug delivery
|
|
WO2004019872A2
(en)
|
2002-08-30 |
2004-03-11 |
Biorexis Pharmaceutical Corporation |
Oral delivery of modified transferrin fusion proteins
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
CA2409552A1
(en)
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
IL162293A0
(en)
|
2001-12-19 |
2005-11-20 |
Alza Corp |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
AUPS088702A0
(en)
*
|
2002-03-04 |
2002-03-28 |
Borody, Thomas Julius |
Electrolyte purgative
|
|
KR20040091100A
(ko)
|
2002-03-04 |
2004-10-27 |
소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. |
운반체 펩타이드를 함유하는 서방형 의약 조성물
|
|
US20030219479A1
(en)
|
2002-04-08 |
2003-11-27 |
Lavipharm Laboratories Inc. |
Multi-layer mucoadhesive drug delivery device with bursting release layer
|
|
GB0214013D0
(en)
|
2002-06-18 |
2002-07-31 |
Euro Celtique Sa |
Pharmaceutical product
|
|
WO2004011271A1
(en)
|
2002-07-31 |
2004-02-05 |
E.I. Du Pont De Nemours And Company |
Ink-jet printed rigid interlayer and a process for preparing same
|
|
AU2003286836A1
(en)
|
2002-10-31 |
2004-06-07 |
Supergen, Inc. |
Pharmaceutical formulations targeting specific regions of the gastrointestinal tract
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
WO2004064769A2
(en)
|
2003-01-21 |
2004-08-05 |
Hector Herrera |
Methods for making and using topical delivery agents
|
|
PL1644021T3
(pl)
*
|
2003-06-13 |
2013-01-31 |
Ironwood Pharmaceuticals Inc |
Sposoby i kompozycje do leczenia zaburzeń żołądkowo-jelitowych
|
|
PL1638529T3
(pl)
|
2003-06-16 |
2017-03-31 |
Andrx Pharmaceuticals, Llc. |
Kompozycja doustna o przedłużonym uwalnianiu
|
|
EA200600598A1
(ru)
|
2003-09-19 |
2006-08-25 |
Пенвест Фармасьютикалз Ко. |
Лекарственные формы замедленного высвобождения
|
|
NZ546183A
(en)
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
|
JP5008980B2
(ja)
|
2003-11-21 |
2012-08-22 |
コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション |
胃腸管送達系
|
|
WO2005063156A1
(en)
|
2003-12-22 |
2005-07-14 |
Shear/Kershman Laboratories, Inc. |
Oral peptide delivery system with improved bioavailability
|
|
JP2007516297A
(ja)
|
2003-12-23 |
2007-06-21 |
アルザ・コーポレーシヨン |
制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
|
|
JP2008507280A
(ja)
|
2004-07-21 |
2008-03-13 |
アンブレツクス・インコーポレイテツド |
非天然コードアミノ酸を用いた生合成ポリペプチド
|
|
US20060051428A1
(en)
|
2004-09-03 |
2006-03-09 |
Nelson Ayala |
Aspartame and citrate flavored phosphate salt laxative
|
|
US7985429B2
(en)
*
|
2006-03-03 |
2011-07-26 |
C. B. Fleet Company, Inc. |
Flavored colonic cleansing system
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
US9333287B2
(en)
*
|
2008-04-08 |
2016-05-10 |
Jet Prep Ltd. |
Body passage cleansing device
|
|
ES2559840T3
(es)
|
2008-06-04 |
2016-02-16 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
JP5964589B2
(ja)
*
|
2008-12-03 |
2016-08-03 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼｃアゴニストの製剤およびその使用方法
|
|
US9616097B2
(en)
*
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
MX357121B
(es)
|
2011-03-01 |
2018-06-27 |
Synergy Pharmaceuticals Inc Star |
Proceso de preparacion de agonistas c de guanilato ciclasa.
|
|
EA201591338A1
(ru)
|
2013-01-15 |
2016-01-29 |
Айронвуд Фармасьютикалз, Инк. |
Гастроретентивная лекарственная форма секвестранта желчных кислот с замедленным высвобождением для перорального применения
|
|
EP2958577A2
(en)
|
2013-02-25 |
2015-12-30 |
Synergy Pharmaceuticals Inc. |
Guanylate cyclase receptor agonists for use in colonic cleansing
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|